Globus Medical, Inc. (NYSE:GMED – Get Free Report) CEO Daniel T. Scavilla offered 60,000 shares of the agency’s inventory in a transaction dated Wednesday, November sixth. The inventory was offered at a median value of $80.02, for a complete transaction of $4,801,200.00. The transaction was disclosed in a submitting with the Securities & Trade Fee, which is accessible by way of this hyperlink.
Globus Medical Inventory Down 1.3 %
Globus Medical inventory opened at $80.88 on Monday. Globus Medical, Inc. has a twelve month low of $43.38 and a twelve month excessive of $84.87. The enterprise has a fifty day shifting common of $72.28 and a two-hundred day shifting common of $68.58. The agency has a market cap of $10.95 billion, a P/E ratio of 120.72, a P/E/G ratio of two.19 and a beta of 1.17.
Globus Medical (NYSE:GMED – Get Free Report) final issued its quarterly earnings knowledge on Tuesday, November fifth. The medical machine firm reported $0.83 earnings per share for the quarter, beating analysts’ consensus estimates of $0.65 by $0.18. The corporate had income of $625.71 million for the quarter, in comparison with the consensus estimate of $604.69 million. Globus Medical had a return on fairness of 9.98% and a internet margin of three.69%. The agency’s income for the quarter was up 63.1% in comparison with the identical quarter final yr. Throughout the identical quarter final yr, the corporate earned $0.57 earnings per share. Equities analysts anticipate that Globus Medical, Inc. will put up 2.97 earnings per share for the present yr.
Institutional Inflows and Outflows
A number of massive buyers have just lately modified their holdings of the corporate. Choose Fairness Group L.P. acquired a brand new stake in Globus Medical within the second quarter valued at roughly $91,711,000. Millennium Administration LLC boosted its place in shares of Globus Medical by 1,171.5% within the 2nd quarter. Millennium Administration LLC now owns 1,363,834 shares of the medical machine firm’s inventory price $93,409,000 after buying an extra 1,256,570 shares within the final quarter. Magnetar Monetary LLC boosted its place in shares of Globus Medical by 198.6% within the 1st quarter. Magnetar Monetary LLC now owns 1,689,287 shares of the medical machine firm’s inventory price $90,613,000 after buying an extra 1,123,540 shares within the final quarter. Motley Idiot Asset Administration LLC grew its stake in Globus Medical by 1,263.7% throughout the 1st quarter. Motley Idiot Asset Administration LLC now owns 848,164 shares of the medical machine firm’s inventory price $45,496,000 after shopping for an extra 785,970 shares over the past quarter. Lastly, Burgundy Asset Administration Ltd. elevated its place in Globus Medical by 46.1% throughout the 1st quarter. Burgundy Asset Administration Ltd. now owns 2,479,837 shares of the medical machine firm’s inventory valued at $133,018,000 after shopping for an extra 782,285 shares within the final quarter. Institutional buyers personal 95.16% of the corporate’s inventory.
Wall Avenue Analyst Weigh In
A number of analysts have issued reviews on GMED shares. Needham & Firm LLC reissued a “maintain” score on shares of Globus Medical in a analysis observe on Wednesday, November sixth. Truist Monetary upped their value goal on Globus Medical from $78.00 to $79.00 and gave the corporate a “maintain” score in a analysis report on Wednesday, August seventh. BTIG Analysis lifted their goal value on Globus Medical from $77.00 to $78.00 and gave the inventory a “purchase” score in a analysis report on Monday, October 14th. Barclays upped their value goal on shares of Globus Medical from $85.00 to $93.00 and gave the inventory an “chubby” score in a report on Thursday, August eighth. Lastly, Financial institution of America lifted their value goal on shares of Globus Medical from $55.00 to $80.00 and gave the corporate an “underperform” score in a report on Wednesday, November sixth. One analyst has rated the inventory with a promote score, three have given a maintain score and eight have assigned a purchase score to the inventory. Based on knowledge from MarketBeat, Globus Medical at the moment has a consensus score of “Reasonable Purchase” and a consensus goal value of $87.09.
Learn Our Newest Inventory Evaluation on Globus Medical
Globus Medical Firm Profile
Globus Medical, Inc, a medical machine firm, develops and commercializes healthcare options for sufferers with musculoskeletal issues in america and internationally. The corporate provides backbone merchandise, akin to conventional fusion implants comprising pedicle screw and rod programs, plating programs, intervertebral spacers, and corpectomy gadgets for treating degenerative and congenital situations, deformity, tumors, and trauma accidents; remedy choices for movement preservation applied sciences that include dynamic stabilization, complete disc alternative, and interspinous distraction gadgets; interventional options to deal with vertebral compression fractures; and regenerative biologic merchandise comprising of allografts and artificial options.
Beneficial Tales
Obtain Information & Scores for Globus Medical Every day – Enter your e mail tackle under to obtain a concise each day abstract of the newest information and analysts’ scores for Globus Medical and associated firms with MarketBeat.com’s FREE each day e mail publication.
